Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 180Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 8Myeloid 2

Conditions

Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Blood Specimen Collection 15Imatinib Mesylate 10Flow Cytometry 10nilotinib 8Surveys and Questionnaires 8Polymerase Chain Reaction 8ponatinib 6Cytogenetic Analysis 6ruxolitinib 5bosutinib 5Psychiatric Rehabilitation 5Dasatinib 5Therapeutics 4Interviews as Topic 4Biopsy 4asciminib 3Observation 3Microarray Analysis 3In Situ Hybridization, Fluorescence 3Immunoenzyme Techniques 3Amplified Fragment Length Polymorphism Analysis 3olverembatinib 2fludarabine 2Watchful Waiting 2Tyrosine Kinase Inhibitors 2Molecular Diagnostic Techniques 2Influenza Vaccines 2Immunologic Techniques 2Immunohistochemistry 2Hydroxyurea 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Azacitidine × Myeloid × Clear all
NCT06390306 2025-06-03

The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP

Peking University People's Hospital

Recruiting
30 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04296214 2021-07-09

Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Grupo Cooperativo de Hemopatías Malignas

Withdrawn
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡